UK Markets closed

Medtronic plc (MDT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
94.82+0.78 (+0.83%)
At close: 04:00PM EDT
94.80 -0.02 (-0.02%)
After hours: 07:45PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3135.89
52-week low 386.70
50-day moving average 391.41
200-day moving average 3103.88

Share statistics

Avg vol (3-month) 35.59M
Avg vol (10-day) 34.27M
Shares outstanding 51.34B
Implied shares outstanding 6N/A
Float 81.33B
% held by insiders 10.25%
% held by institutions 183.92%
Shares short (14 Jul 2022) 410.22M
Short ratio (14 Jul 2022) 41.83
Short % of float (14 Jul 2022) 40.77%
Short % of shares outstanding (14 Jul 2022) 40.77%
Shares short (prior month 14 Jun 2022) 410.21M

Dividends & splits

Forward annual dividend rate 42.72
Forward annual dividend yield 42.94%
Trailing annual dividend rate 32.42
Trailing annual dividend yield 32.57%
5-year average dividend yield 42.13
Payout ratio 467.56%
Dividend date 314 Jul 2022
Ex-dividend date 422 Jun 2022
Last split factor 22:1
Last split date 326 Sept 1999

Financial highlights

Fiscal year

Fiscal year ends 28 Apr 2022
Most-recent quarter (mrq)28 Apr 2022

Profitability

Profit margin 15.90%
Operating margin (ttm)20.84%

Management effectiveness

Return on assets (ttm)4.48%
Return on equity (ttm)9.70%

Income statement

Revenue (ttm)31.69B
Revenue per share (ttm)23.60
Quarterly revenue growth (yoy)-1.20%
Gross profit (ttm)21.66B
EBITDA 9.31B
Net income avi to common (ttm)5.04B
Diluted EPS (ttm)3.47
Quarterly earnings growth (yoy)9.20%

Balance sheet

Total cash (mrq)10.57B
Total cash per share (mrq)7.96
Total debt (mrq)24.98B
Total debt/equity (mrq)47.39
Current ratio (mrq)1.86
Book value per share (mrq)38.66

Cash flow statement

Operating cash flow (ttm)7.35B
Levered free cash flow (ttm)4.9B